CHEMOTHERAPY OF ADVANCED GASTRIC-CARCINOMA - TO BE COMPLETELY REWRITTEN

被引：18

作者：

COCCONI, G

机构：

来源：

ANNALS OF ONCOLOGY | 1994年 / 5卷 / 01期

关键词：

D O I：

10.1093/oxfordjournals.annonc.a058701

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：8 / 11

页数：4

共 24 条

[11] FAMTX VERSUS ETOPOSIDE, DOXORUBICIN, AND CISPLATIN - A RANDOM ASSIGNMENT TRIAL IN GASTRIC-CANCER
KELSEN, D
ATIQ, OT
SALTZ, L
NIEDZWIECKI, D
GINN, D
CHAPMAN, D
HEELAN, R
LIGHTDALE, C
VINCIGUERRA, V
BRENNAN, M
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) : 541 - 548
[12] KLEIN HO, 1989, ANTICANCER RES, V9, P1025
[13] KOVACH JS, 1974, CANCER-AM CANCER SOC, V33, P563, DOI 10.1002/1097-0142(197402)33:2<563::AID-CNCR2820330235>3.0.CO
[14] 2-K
[15] CISPLATINUM AS 2ND-LINE CHEMOTHERAPY IN ADVANCED GASTRIC ADENOCARCINOMA - A PHASE-II STUDY OF THE EORTC GASTROINTESTINAL-TRACT CANCER COOPERATIVE GROUP
LACAVE, AJ
WILS, J
DIAZRUBIO, E
CLAVEL, M
PLANTING, A
BLEIBERG, H
DUEZ, N
DALESIO, O
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (11): : 1321 - 1324
[16] LACAVE AJ, 1983, AM J CLIN ONCOL-CANC, V6, P35
[17] HIGH-DOSE FOLINIC ACID, 5-FLUOROURACIL BOLUS AND CONTINUOUS INFUSION IN POOR-PROGNOSIS PATIENTS WITH ADVANCED MEASURABLE GASTRIC-CANCER
LOUVET, C
DEGRAMONT, A
DEMUYNCK, B
NORDLINGER, B
MAISANI, JE
LAGADEC, B
DELFAU, S
VARETTE, C
GONZALEZCANALI, G
KRULIK, M
[J]. ANNALS OF ONCOLOGY, 1991, 2 (03) : 229 - 230
[18] 5-FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN (FAM) COMBINATION CHEMOTHERAPY FOR ADVANCED GASTRIC-CANCER
MACDONALD, JS
SCHEIN, PS
WOOLLEY, PV
SMYTHE, T
UENO, W
HOTH, D
SMITH, F
BOIRON, M
GISSELBRECHT, C
BRUNET, R
LAGARDE, C
[J]. ANNALS OF INTERNAL MEDICINE, 1980, 93 (04) : 533 - 536
[19] MACDONALD JS, 1982, CANCER PRINCIPLES PR, P534
[20] TREATMENT OF ADVANCED COLORECTAL AND GASTRIC ADENOCARCINOMAS WITH 5-FLUOROURACIL AND HIGH-DOSE FOLINIC ACID
MACHOVER, D
GOLDSCHMIDT, E
CHOLLET, P
METZGER, G
ZITTOUN, J
MARQUET, J
VANDENBULCKE, JM
MISSET, JL
SCHWARZENBERG, L
FOURTILLAN, JB
GAGET, H
MATHE, G
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (05) : 685 - 696

← 1 2 3 →